A Randomized, Double-blind, Placebo-controlled Study of Effects of Two Fixed-dose Leucine-sildenafil Combinations (NS-0300) or Two Fixed-dose Leucine-sildenafil-metformin Combinations (NS-0200) Versus Placebo on Body Weight in Obesity
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Leucine/metformin/sildenafil (Primary) ; Leucine/sildenafil (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 01 Jan 2021 Results published in the American Journal of Therapeutics
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 29 Oct 2018 Status changed from recruiting to completed.